Access all of the content
So pleased to have had an opportunity to catch-up with editorial board member, K Ray Chaudhuri (King’s Parkinson’s Centre, King’s College Hospital and Kings College London, UK), who shared his expert perspective on the clinical impact of COVID-19 on people with Parkinson’s disease.
1. What treatment strategies should be implemented in patients with Parkinson’s disease (PD) and pneumonia or upper respiratory tract infections resulting from COVID-19? (0:05)
2. What potential drug–drug interactions may occur between PD medications and drugs used to treat symptoms of COVID-19? (2:06)
3. What are the consequences of anxiety and prolonged immobility due to the lockdown on patients with PD? (2:49)
4. What other advice would you like to impart to healthcare professionals regarding patient management at this time? (4:39)
Also see linked video: K Ray Chaudhuri, EAN 2020 – Clinical Impact of COVID-19 on People With Parkinson’s Disease
Speaker disclosure: K Ray Chaudhuri has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media.
Filmed at the 6th Congress of the European Academy of Neurology (EAN) and 1st EAN Virtual Congress, May 2020.
Share this Video
Related Videos In Parkinson's Disease
Angelo Antonini, EAN 2023: Highlights in Parkinson’s disease
touchNEUROLOGY editorial board member Prof. Angelo Antonini (Padua University Hospital, Italy) provides an overview of his top three most important updates and hot topics from the annual European Academy of Neurology (EAN), July 1–4, 2023, in the field of Parkinson’s disease. He particularly focusses on new insights in early detection of the disease before motor symptoms […]
Highlights from EAN 2023!
Veronica Clark, Parkinson’s Europe: Presidential Update, and the Parkinson’s Manifesto for Europe
The European Parkinson’s Disease Association (EPDA) recently changed its name to Parkinson’s Europe. They are the only European Parkinson’s umbrella organisation and have been working with the global Parkinson’s community for nearly 30 years. As a leading voice for Parkinson’s in Europe, they provide trusted information; advance and share good practices; raise awareness and improve […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!